文献速递肝胆胰外科围术期管理与 ERAS

减重手术后肝腺瘤消退:病例系列与系统综述

Hepatic adenoma regression after bariatric surgery: a case series and systematic review.
PubMed 文献 · Surg Endosc · 2025-11-10

平均BMI从44.48 kg/m2降至32.19 kg/m2,%EWL达68.18%,肝腺瘤平均大小从4.49 cm降至1.55 cm(缩小56.46%),40%患者完全消退。%EWL与肝腺瘤缩小显著相关(Kendall's Tau-b=0.5528,p=0.047)。

要点

  • 减重手术与肝腺瘤高消退率相关,40%患者完全消退。
  • %EWL每增加1%,肝腺瘤大小平均缩小0.76%(95%CI -1.18至-0.34,p<0.001)。
  • 对肥胖肝腺瘤患者,减重手术可考虑作为初始管理选项。

核心结论

  • 减重手术与肝腺瘤高消退率相关,可考虑作为肥胖肝腺瘤患者的初始管理选项。

主要发现

  • 平均年龄34.8岁,术前平均BMI 44.48 kg/m2,术后降至32.19 kg/m2,%EWL为68.18%。
  • 肝腺瘤平均大小从4.49 cm降至1.55 cm,缩小56.46%(SD 43.68),40%患者完全消退。
  • %EWL与肝腺瘤缩小显著相关(Kendall's Tau-b=0.5528,p=0.047)。
  • 分数概率回归边际效应显示,%EWL每增加1%,肝腺瘤大小缩小0.76%(95%CI -1.18至-0.34,p<0.001)。

临床怎么用

  • 对于肥胖合并肝腺瘤患者,减重手术可作为初始管理选项,利用减重获益促进肝腺瘤消退。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Hepatic adenomas (HA) are benign neoplasms of the liver that have small risks of hemorrhage and malignant transformation. While the association between obesity and the development of HAs is increasingly recognized, the impact of bariatric surgery on HA regression is poorly understood. METHODS: All patients with a pre-operative diagnosis of HA who underwent primary bariatric surgery (sleeve gastrectomy or Roux-en-Y gastric bypass) at a single quaternary academic medical center from 2012 to 2024 were retrospectively queried and combined with all previously reported cases obtained via a systematic review of the literature. Patient clinical characteristics, including pre-operative and post-operative body mass index (BMI) and HA size, were extracted. Kendall's Tau-b correlation and fractional probit regression were used to assess the relationship between weight loss and HA size change. RESULTS: The institutional review identified three patients, and the systematic review yielded five studies totaling seven patients. In the combined cohort (mean age 34.8 years), the average pre-operative BMI was 44.48 kg/m2 and decreased to 32.19 kg/m2 post-operatively, representing 68.18% excess weight loss (%EWL). Mean HA size decreased from 4.49 cm to 1.55 cm (56.46% reduction, SD 43.68), with 40% of patients experiencing complete regression. %EWL was significantly associated with HA size reduction (Kendall's Tau-b: 0.5528; p = 0.047). Marginal effects following fractional probit regression analysis showed that each additional percentage increase in %EWL was associated with 0.76% HA size reduction (95% CI: -1.18, -0.34; p < 0.001). CONCLUSIONS: In this combined case series and systematic review of the literature, bariatric surgery was associated with high rates of HA regression. Given the additional benefits of weight loss from bariatric surgery and the significant morbidity associated with liver resection, bariatric surgery could be considered as an initial management option for obese patients with HA.

来源:Surg Endosc,查看原文。版权归原作者所有。

引用

  1. Garbarine IC, Walsh AK, Pawlik TM, et al. Hepatic adenoma regression after bariatric surgery: a case series and systematic review. Surg Endosc. 2025. PMID: 41214355. doi:10.1007/s00464-025-12350-8

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。